Literature DB >> 15678622

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion.

Eric P Brass1, William R Hiatt, Simon Green.   

Abstract

Patients with claudication have a marked impairment in exercise performance. Several factors contribute to this limitation, including reductions in large vessel blood flow and oxygen delivery as well as metabolic abnormalities in skeletal muscle. The relative contribution of these factors and their role in the pathophysiology of the exercise limitation is discussed using a point-counterpoint approach. Future directions for research conclude the discussion.

Entities:  

Mesh：

Year:  2004        PMID： 15678622     DOI： 10.1191/1358863x04vm572ra

Source DB:  PubMed          Journal:  Vasc Med        ISSN： 1358-863X            Impact factor:   3.239


  25 in total

1.  Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.

Authors:  Jennifer L Robbins; W Schuyler Jones; Brian D Duscha; Jason D Allen; William E Kraus; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication.

Authors:  Emile R Mohler; John L Gainer; Kim Whitten; Luis H Eraso; Porama Koy Thanaporn; Timothy Bauer
Journal:  Vasc Med       Date:  2011-10       Impact factor: 3.239

3.  Venous occlusion plethysmography versus Doppler ultrasound in the assessment of leg blood flow during calf exercise.

Authors:  Simon Green; R Thorp; E J Reeder; J Donnelly; G Fordy
Journal:  Eur J Appl Physiol       Date:  2011-01-14       Impact factor: 3.078

4.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

Review 5.  Nitrite and nitric oxide metabolism in peripheral artery disease.

Authors:  Jason D Allen; Tony Giordano; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2012-03-14       Impact factor: 4.427

Review 6.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

Review 7.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

8.  Venous occlusion plethysmography vs. Doppler ultrasound in the assessment of leg blood flow kinetics during different intensities of calf exercise.

Authors:  Elaine Murphy; Joel Rocha; Norita Gildea; Simon Green; Mikel Egaña
Journal:  Eur J Appl Physiol       Date:  2017-11-30       Impact factor: 3.078

9.  Femoral artery occlusion augments TRPV1-mediated sympathetic responsiveness.

Authors:  Jihong Xing; Zhaohui Gao; Jian Lu; Lawrence I Sinoway; Jianhua Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

Review 10.  Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease.

Authors:  Naomi M Hamburg; Nicholas J Leeper
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.